Active Ingredient History
Blood is a body fluid in the circulatory system of humans and other vertebrates that delivers necessary substances such as nutrients and oxygen to the cells, and transports metabolic waste products away from those same cells. Blood in the circulatory system is also known as peripheral blood, and the blood cells it carries, peripheral blood cells. Wikipedia
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Allogeneic Cells (Phase 2)
Anemia, Sickle Cell (Phase 1/Phase 2)
Angina Pectoris (Phase 2)
Atherosclerosis (Phase 3)
Cartilage Diseases (Phase 2)
Cerebral Palsy (Phase 1/Phase 2)
Chest Pain (Phase 1/Phase 2)
Chronic Limb-Threatening Ischemia (Phase 3)
Coronary Artery Disease (Phase 1/Phase 2)
Diabetic Foot (Phase 1/Phase 2)
Enterocolitis, Neutropenic (Phase 1/Phase 2)
Fallopian Tube Neoplasms (Phase 2)
Gangrene (Phase 3)
Glioblastoma (Phase 2)
Glioma (Phase 2)
Graft vs Host Disease (Phase 2)
Granulocyte Colony-Stimulating Factor (Phase 1/Phase 2)
Hamartoma (Phase 2)
Healthy Volunteers (Phase 1)
Hematologic Neoplasms (Phase 1/Phase 2)
Ischemia (Phase 1/Phase 2)
Kidney Failure, Chronic (Phase 1/Phase 2)
Leg Ulcer (Phase 1/Phase 2)
Leukemia, Lymphocytic, Chronic, B-Cell (Phase 1)
Leukemia, Myelogenous, Chronic, BCR-ABL Positive (Phase 1/Phase 2)
Leukemia, Myeloid, Acute (Phase 1/Phase 2)
Leukocytes, Mononuclear (Phase 1/Phase 2)
Lymphoma, Non-Hodgkin (Phase 1)
Melanoma (Phase 3)
Multiple Myeloma (Phase 1/Phase 2)
Myelodysplastic Syndromes (Phase 1/Phase 2)
Myocardial Infarction (Phase 1/Phase 2)
Myocardial Ischemia (Phase 2)
Neoplasms (Phase 1/Phase 2)
Neurodegenerative Diseases (Phase 2)
Ovarian Neoplasms (Phase 2)
Pain (Phase 2)
Peripheral Vascular Diseases (Phase 1/Phase 2)
Precursor Cell Lymphoblastic Leukemia-Lymphoma (Phase 1/Phase 2)
Prostheses and Implants (Phase 2)
Ulcer (Phase 3)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue